Nachrichten zur Vanda Pharmaceuticals Aktie

Vanda Pharmaceuticals Inc. (VNDA) Q3 2024 Earnings Call Transcript

…

Vanda Pharmaceuticals rejects Cycle Pharmas second takeover offer By Reuters

Vanda Pharmaceuticals rejects Cycle Pharmas second takeover offer…

Cycle Pharmaceuticals Stands By $488 Million Offer for Vanda

Cycle Pharmaceuticals Ltd. is still interested in acquiring Vanda Pharmaceuticals Inc. after one of Vanda’s drugs failed to receive regulatory…

Vanda Pharmaceuticals: I Believe That The Bidding War Is Not Over

…

Court advances Vanda Pharmaceuticals patent case By Investing.com

Court advances Vanda Pharmaceuticals patent case…

Vanda Pharmaceuticals drops after Future Pak walks away

…

Vanda Pharmaceuticals: Undervalued With Promising Pipeline And Acquisition Interest

…

Global Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98%

The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…

Vanda Pharmaceuticals rejects sweetened bid from Future Pak

…

Vanda Pharmaceuticals, Inc. (VNDA) Q1 2024 Earnings Call Transcript

…

U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents By Reuters

U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents…

Vanda Pharmaceuticals: Fanapt Bipolar Win Doesnt Change Much

…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA

NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA

NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

Dyspepsia Drug Pipeline Insight Report 2024 Featuring Vanda Pharmaceuticals, Dong-A ST, and Dexa Medica Group

Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Dyspepsia - Pipeline Insight, 2024" report has been added to…

Vanda Pharmaceuticals Portfolio Likely Has Upside From 2024 Approvals, Underpinned By Cash

…

Vanda Pharmaceuticals: FDA Approvals On Deck In 2024 Makes This A Must Watch

…

Vanda Pharmaceuticals Inc. (VNDA) Q3 2023 Earnings Call Transcript

…

Vanda Pharmaceuticals: Value In The Biotech Space

…

Form 8-K Vanda Pharmaceuticals For: Aug 16

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: SVP, CFO & Treasurer verkauft Aktien von Vanda Pharmaceuticals im Wert von 13.945$

Moran, Kevin Patrick - Vorstand - Tag der Transaktion: 2023-07-28...…

Form 10-Q Vanda Pharmaceuticals For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vanda Pharmaceuticals to Announce Second Quarter 2023 Financial Results on July 27, 2023

Conference Call and Webcast to Follow WASHINGTON, July 20, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced…

Just Weeks After "Capitulating" On Stocks, Retail Buyers Are Back With A Vengeance

Just Weeks After "Capitulating" On Stocks, Retail Buyers Are Back With A Vengeance …

Form 8-K Vanda Pharmaceuticals For: Jun 08

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vanda Pharmaceuticals Announces Participation in the Jefferies 2023 Global Healthcare Conference

WASHINGTON, June 5, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in…

Vanda gains on FDA orphan drug designation for nerve disorder candidate

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vanda to consider options after appeals court ruling on Hetlioz generics

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Watch Vanda Insights on Oil Outlook

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q Vanda Pharmaceuticals For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vanda Pharmaceuticals Reports First Quarter 2023 Financial Results

Q1 2023 total revenues were $62.5 million Vanda provides update on three upcoming regulatory submissions WASHINGTON, May 3, 2023 /PRNewswire/…

Vanda Pharmaceuticals sues U.S. government over drug trade secrets

...By Blake Brittain (Reuters) - Vanda Pharmaceuticals Inc has sued......…

Vanda Pharmaceuticals Sues U.S. Government Over Alleged Misuse of Confidential Drug Data

Vanda Pharmaceuticals Sues U.S. Government Over Alleged Misuse of Confidential Drug Data...…

Vanda Pharmaceuticals to Announce First Quarter 2023 Financial Results on May 3, 2023

Conference Call and Webcast to Follow WASHINGTON, April 27, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced…

Vanda wins FOIA litigation against FDA regarding Hetlioz for jet lag

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Despite market volatility, retail investors went on a buy-the-dip spree. These are the stocks they picked up, says Vanda.

Churning financial markets, as the failure of three U.S. banks and uncertainty over one big European one continues to play…

dpa-AFX ProFeed